Regional Conference Baltimore, MD

Location: Baltimore, MD
Date: December 4-7, 2013

Meeting Overview

Venue:
Baltimore Convention Center
Primary Audience:
Primary Care
Credits:
Refer to the Accreditation Tab

Pri-Med Baltimore 2014
December 8–10
Hilton Baltimore
Learn More »

**Registration is now closed**

View the 2014 Annual Conference schedule:
View Annual Conference schedule »

Explore the online library of activities and earn CME credits today:
Earn CME Credits Online »

CME created with you in mind

Now more than ever, clinicians are challenged by their expanded roles, their limited time, and the need to provide patient care across an ever-broadening array of disease and comorbid conditions.

Pri-Med Baltimore, a complimentary four-day CME program, was developed to meet your needs as a clinician on the front lines of care.

The curriculum for this unique multi-day educational conference covers topics including evidence-based best practices in diabetes, immunizations updates, and even does a deep-dive into arthritis management. You will acquire up-to-date clinical knowledge that is easily translated into practice, completely free of charge.

View the session schedule»

Get the most value for your time 

  • Attend over 20 cutting-edge sessions—for free!
  • Earn up to 20 AMA PRA Category 1 Credits™ or 20 AANP contact hours of continuing education.
  • Participate in a SAFE Opioid Prescribing certification series.
  • Learn from expert faculty and have your questions answered. during the Q&A portion of each CME session.
  • Network with your colleagues.

Need another reason to attend?

Keep your brain energized.

A continuation of one of last year’s favorites, the Medical Brain Game—SAFE Opioid Prescribing Edition session presents clinical guidelines in a trivia-style, friendly competition with your peers. You might even win a prize.

View the national conference schedule »

*Primary Care Updates is sponsored by pmiCME and produced independently of and are not affiliated with the American College of Physicians. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

**Presentation Theaters and the Product Forum are not offered for CME credit nor is the content planned or reviewed by pmiCME or ACP.

†Earn up to an additional 9.25 AMA PRA Category 1 Credits™ on
December 4, 2013, at Primary Care Updates and Integrated Approaches to Cardiometabolic Care; seating is extremely limited for these two programs.

Comprehensive CME Program
Pri-Med doctor

Primary Care Updates*
December 4, 2013 | Morning 
CME sessions that focus on cardiometabolic disease-specific treatment and management approaches. Seating is extremely limited.

Integrated Approaches to Cardiometabolic Care
Decmeber 4, 2013 | Afternoon
Innovative new CME sessions for PCPs, cardiologists, and endocrinologists who jointly manage patients with complex cardiometabolic conditions. Case studies, lectures, and a panel discussion will cover treatment decisions for high-risk patients.

Primary Care Updates*
December 5, 2013
A multi-track day of CME programs to supplement your education.

Regional Conference
December 6–7, 2013
CME curriculum developed in collaboration with the American College of Physicians (ACP), covering the latest topics in primary care medicine


Industry-Sponsored Opportunities

Presentation Theaters**
Get an in-depth look at the latest tools and treatment options in these ticketed, complimentary presentations. Learn More »

Product Forum**
Engage with medical industry representatives on your terms. Meet local contacts who understand that you don’t have time to talk with them at your practice.

 

Sessions & Syllabus

View the session schedule summary here.
Print Syllabus
Wednesday, December 04, 2013
Thursday, December 05, 2013
Friday, December 06, 2013
6:45 AM-7:30 AM
Registration and Breakfast
7:30 AM-7:45 AM
Opening Remarks
7:45 AM-8:15 AM
Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
Complete all 6 sessions and you will receive REMS compliant training certificate. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA). This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies.

Learning Objectives:

  1. Identify risk factors for opioid-related aberrant behavior
  2. Differentiate between tolerance, physical dependence and addiction
Charles Argoff MDAssistant Professor of Neurology, New York University School of Medicine, New York, NY, Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY
Bill McCarberg MD (Read Bio) Assistant Clinical Professor (voluntary), University of California, San Diego, San Diego, CA, Founder, Chronic Pain Management Program, San Diego, CA
Steven Stanos DO (Read Bio) Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of Medicine, Chicago, IL, Chronic Pain Care Center, Chicago, IL
8:15 AM-8:45 AM
Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
Improve your ability to adjust treatment when converting from immediate release opioid formulations to extended release/long-acting preparations, as well as your ability to identify risk factors for opioid-induced respiratory depression.

Learning Objectives:

  1. Convert patients from immediate-release to ER/LA opioids as well as from one ER/LA opioid to another
  2. Identify predisposing risk factors for significant respiratory depression
Charles Argoff MD
Bill McCarberg MD (Read Bio)
Steven Stanos DO (Read Bio)
8:45 AM-9:15 AM
Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
Improve your ability to manage adverse reactions with extended release/long-acting opioid formulations and to monitor patient adherence to treatment.

Learning Objectives:

  1. Evaluate and manage adverse effects of ER/LA-opioids
  2. Differentiate strategies for monitoring patient adherence
Charles Argoff MD
Bill McCarberg MD (Read Bio)
Steven Stanos DO (Read Bio)
9:15 AM-10:15 AM
Refreshment Break and Additional Opportunities
10:15 AM-11:00 AM
Talk to Me: Proven Methods to Counsel You Patients on ER/LA Opioids and Achieve Positive Outcomes
This session will provide important take away strategies for counseling patients and caregivers to ensure appropriate use of extended release/long-acting opioids and recognition of signs of overdose.

Learning Objectives:

  1. Implement counseling strategies to ensure patients know to take ER/LA opioids exactly as prescribed
  2. Use counseling strategies to explain signs of ER/LA opioid overdose to patients and caregivers
Charles Argoff MDAssistant Professor of Neurology, New York University School of Medicine, New York, NY, Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY
Bill McCarberg MD (Read Bio) Assistant Clinical Professor (voluntary), University of California, San Diego, San Diego, CA, Founder, Chronic Pain Management Program, San Diego, CA
Steven Stanos DO (Read Bio) Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of Medicine, Chicago, IL, Chronic Pain Care Center, Chicago, IL
11:00 AM-11:30 AM
Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
When individualizing your pain management treatment approach, learn how to assess differences in opioid metabolism and potential drug interactions in your patient, and how these factors will impact treatment.

Learning Objectives:

  1. Assess the differences in opioid metabolism and how these impact appropriate ER/LA prescribing
  2. Identify how opioid-drug interactions influence ER/LA opioid prescribing
Charles Argoff MD
Bill McCarberg MD (Read Bio)
Steven Stanos DO (Read Bio)
11:30 AM-12:15 PM
Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
Improve your understanding of the official prescribing information for available extended release/long-acting opioids, as well as the doses indicated for opioid-tolerant patients

Learning Objectives:

  1. Differentiate the prescribing information among available ER/LA opioids
  2. Identify ER/LA opioids and dosages indicated for opioid-tolerant patients only
Charles Argoff MDAssistant Professor of Neurology, New York University School of Medicine, New York, NY, Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY
Bill McCarberg MD (Read Bio) Assistant Clinical Professor (voluntary), University of California, San Diego, San Diego, CA, Founder, Chronic Pain Management Program, San Diego, CA
Steven Stanos DO (Read Bio) Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of Medicine, Chicago, IL, Chronic Pain Care Center, Chicago, IL
12:15 PM-2:00 PM
Lunch and Additional Opportunities
2:00 PM-3:00 PM
Lung Sounds: A Primer on Pulmonary Auscultation
This primer on pulmonary auscultation will permit you to identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently, and link them to the scientific and literature validation that supports their clinical relevancy.

Learning Objectives:

  1. Recognize and identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently.
  2. Link literature validation and scientific basis to those sounds and extra-sounds which are clinically relevant.
  3. Establish a clinico-pathologic correlation for sounds and extra-sounds and murmurs.
Salvatore Mangione MD (Read Bio) Associate Professor of Medicine, Jefferson Medical College, Philadelphia, PA
3:00 PM-4:00 PM
The Problem Pests: Ticks, Mites, Bed Bugs, and Lice
This session will provide you with actionable information regarding insect pest borne infectious diseases, including the topic of the manifestations of Lyme disease and test interpretation to manage these patients and identifying body lice infestation with patient education regarding treatment and prevention.

Learning Objectives:

  1. Consider the manifestations of Lyme disease and testing interpretation in order to appropriately manage patients with suspected infection
  2. Identify body lice and educate patients and families about treatment and infestation prevention
Stephen Gluckman MD (Read Bio) Professor of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Medical Director, Penn Global Medicine, Philadelphia, PA
4:00 PM-4:15 PM
Networking Break
4:15 PM-5:30 PM
Targeting Better Cardiac Outcomes for High-Risk Patients
This session will provide important update information on low HDL-C levels and elevated triglycerides as therapeutic targets to reduce cardiovascular disease risk.

Learning Objectives:

  1. Evaluate recent clinical trials with respect to management of low HDL
  2. Examine the data on triglycerides and CVD risk to determine how aggressively to treat patients with elevated TGs
  3. Employ strategies for reducing CVD risk in patients with type 2 diabetes and hypertension
Danielle Duffy FACC, MD (Read Bio) Assistant Professor of Medicine, Division of Cardiology, Jefferson Medical College, Philadelphia, PA, Director, Cardiovascular Risk Reduction, Jefferson Heart Institute, Philadelphia, PA
Saturday, December 07, 2013
6:45 AM-7:30 AM
Registration and Breakfast
7:30 AM-7:45 AM
Opening Remarks
7:45 AM-9:00 AM
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis and pulmonary embolism. This session will assist you in identifying high risk medical and hospitalized patients in whom thromboprophylaxis should be initiated and appropriate oral regimens for extended thromboprophylaxis after hospital discharge.

Learning Objectives:

  1. Identify high risk medical and hospitalized patients for whom thromboprophylaxis should be initiated
  2. Determine appropriate oral regimens for extended thromboprophylaxis after hospital discharge
Gregory Piazza MD (Read Bio) Cardiovascular Division, Brigham and Women's Hospital, Instructor in Medicine, Harvard Medical School, Boston, MA, Education Chair, NATF, Brookline, MA
9:00 AM-10:00 AM
Refreshment Break and Additional Opportunities
10:00 AM-12:00 PM
Live Demonstration Orthopedic Exam: See It, Do It
Learn orthopedic maneuvers to assess common office-based musculoskeletal complaints.

Learning Objectives:

  1. Improve your ability to diagnose common musculoskeletal complaints including upper body, low back, hip, and knee
Christopher Smith MD, FACP (Read Bio) Associate Proessor of Medicine, Harvard Medical School, Boston, MA, Associate Director, Internal Medicine Residency Program, Co-Director, Rabkin Fellowship in Medical Education, Beth Israel Deaconess Medical Center, Boston, MA
12:00 PM-1:00 PM
Lunch and Additional Opportunities
1:00 PM-2:00 PM
Critical Caveats for Common Medications
Case-based review of side effects and drug interations encountered with commonly used medications including proton pump inhibitors, triptans, antibiotics, anticoagulants, NSAIDs, and antidepressants.

Learning Objectives:

  1. Effectively manage patients who are on statin therapy with respect to potential drug interactions and muscle-related symptoms
  2. Consider potential adverse effects of proton pump inhibitors, such as impaired absorption of certain nutrients, when prescribing as long-term therapy
Douglas S. Paauw MD (Read Bio) Professor of Medicine, Rothman Family Foundation, Endowed Chair in Patient-Centered Clinical Education, University of Washington School of Medicine, Seattle, WA
2:00 PM-3:00 PM
Refreshment Break and Additional Opportunities
2:15 PM-3:15 PM
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
Improve your recognition of the signs and symptoms of major depressive disorder with differentiation from bipolar disorder. Improve your knowledge in the best practice selection of pharmacologic treatments for patients with uncomplicated depression and somatization.

Learning Objectives:

  1. Recognize the signs and symptoms of major depressive disorder and initiate therapy with close monitoring
  2. Differentiate bipolar disease from symptoms of depression in order to determine appropriate treatment
  3. Consider actions and side effects of drugs and drug classes when deciding on which treatment to select for specific patients with psychiatric disorders
Rosalind D Kaplan FACP, MD (Read Bio) Director, Temple Health Women's Care, Temple University School of Medicine, Philadelphia, PA, Associate Professor of Clinical Medicine, Temple University School of Medicine, Philadelphia, PA
3:15 PM-4:15 PM
Eating Disorders For the Medical Practitioner
Rosalind D Kaplan FACP, MD (Read Bio) Director, Temple Health Women's Care, Temple University School of Medicine, Philadelphia, PA

Ticketed Events

Breakfast

CME Educational Symposia

6:00 AM-7:30 AM

Alzheimer's Disease

Morning Break

Non-CME Presentation Theater

9:25 AM-10:10 AM

Depression

12:25 PM-1:10 PM

Acute Coronary Syndrome

Lunch Break

CME Educational Symposia

12:30 PM-2:00 PM

Alzheimer's Disease

Dinner

CME Educational Symposia

5:45 PM-7:15 PM

Alzheimer's Disease

Morning Break

Non-CME Presentation Theater

9:10 AM-9:55 AM

Ankylosing Spondylitis

9:25 AM-10:10 AM

Atrial Fibrillation / Stroke

Lunch Break

Non-CME Presentation Theater

12:10 PM-12:55 PM

Pneumococcal Disease in Adults 50+

12:10 PM-12:55 PM

Diabetes

Afternoon Break

CLOSE  X  
Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
Learning Objectives:
  1. Describe the pathophysiologic underpinnings of Alzheimer’s disease, including the role of amyloid ß
  2. Identify patients with risk factors and clinical symptoms that suggest a more formal evaluation for Alzheimer’s disease is warranted
  3. Employ new diagnostic criteria for mild cognitive impairment and dementia due to Alzheimer’s disease from the nation Institute on Aging - Alzheimer’s Association
  4. Discuss options for biomarker testing and brain imaging in patients who are being evaluated for Alzheimer’s disease
  5. Evaluate emerging therapeutic approaches that target aberrant amyloid production and deposition in patients with Alzheimer’s disease
Faculty:
  1. Adam Fleisher, MAS , MD, Director of Imaging, Banner Alzheimer's InstitutePhoenix, AZ, Medical Director, Alzheimer's Disease Cooperative StudyPhoenix, AZ, Associate Professor, Department of Neurosciences, University of CaliforniaSan Diego, CA
  2. Michael Rafii, MD, PhD, Director, Memory Disorders Clinic, University of California, San Diego Perlman Ambulatory Care CenterLa Jolla, CA, Assistant Professor of Neurosciences, University of California, San DiegoSan Diego, CA
  3. Eric Tangalos, MD, FACP, Professor of Medicine, Mayo ClinicRochester, MN
  4. Dennis Selkoe, MD, The Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical SchoolBoston, MA, Co-Director, Center for Neurologic Diseases, Department of Neurology, Brigham and Women's HospitalBoston, MA
The CME activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
CLOSE  X  
Discussion of a Treatment Option for Major Depressive Disorder
Faculty:
  1. Vladimir Maletic, MD, MS
CLOSE  X  
Current Management Strategies in the Treatment of Acute Coronary Syndrome
Faculty:
  1. Jerald Insel, MD, FACC, FSCAI
CLOSE  X  
Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
Learning Objectives:
  1. Describe the pathophysiologic underpinnings of Alzheimer’s disease, including the role of amyloid ß
  2. Identify patients with risk factors and clinical symptoms that suggest a more formal evaluation for Alzheimer’s disease is warranted
  3. Employ new diagnostic criteria for mild cognitive impairment and dementia due to Alzheimer’s disease from the nation Institute on Aging - Alzheimer’s Association
  4. Discuss options for biomarker testing and brain imaging in patients who are being evaluated for Alzheimer’s disease
  5. Evaluate emerging therapeutic approaches that target aberrant amyloid production and deposition in patients with Alzheimer’s disease
Faculty:
  1. Adam Fleisher, MAS , MD, Director of Imaging, Banner Alzheimer's InstitutePhoenix, AZ, Medical Director, Alzheimer's Disease Cooperative StudyPhoenix, AZ, Associate Professor, Department of Neurosciences, University of CaliforniaSan Diego, CA
  2. Michael Rafii, MD, PhD, Director, Memory Disorders Clinic, University of California, San Diego Perlman Ambulatory Care CenterLa Jolla, CA, Assistant Professor of Neurosciences, University of California, San DiegoSan Diego, CA
  3. Eric Tangalos, MD, FACP, Professor of Medicine, Mayo ClinicRochester, MN
  4. Dennis Selkoe, MD, The Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical SchoolBoston, MA, Co-Director, Center for Neurologic Diseases, Department of Neurology, Brigham and Women's HospitalBoston, MA
The CME activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
CLOSE  X  
Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
Learning Objectives:
  1. Describe the pathophysiologic underpinnings of Alzheimer’s disease, including the role of amyloid ß
  2. Identify patients with risk factors and clinical symptoms that suggest a more formal evaluation for Alzheimer’s disease is warranted
  3. Employ new diagnostic criteria for mild cognitive impairment and dementia due to Alzheimer’s disease from the nation Institute on Aging - Alzheimer’s Association
  4. Discuss options for biomarker testing and brain imaging in patients who are being evaluated for Alzheimer’s disease
  5. Evaluate emerging therapeutic approaches that target aberrant amyloid production and deposition in patients with Alzheimer’s disease
Faculty:
  1. Adam Fleisher, MAS , MD, Director of Imaging, Banner Alzheimer's InstitutePhoenix, AZ, Medical Director, Alzheimer's Disease Cooperative StudyPhoenix, AZ, Associate Professor, Department of Neurosciences, University of CaliforniaSan Diego, CA
  2. Michael Rafii, MD, PhD, Director, Memory Disorders Clinic, University of California, San Diego Perlman Ambulatory Care CenterLa Jolla, CA, Assistant Professor of Neurosciences, University of California, San DiegoSan Diego, CA
  3. Eric Tangalos, MD, FACP, Professor of Medicine, Mayo ClinicRochester, MN
  4. Dennis Selkoe, MD, The Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical SchoolBoston, MA, Co-Director, Center for Neurologic Diseases, Department of Neurology, Brigham and Women's HospitalBoston, MA
The CME activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
CLOSE  X  
Inflammatory Back Pain Recognition and Diagnosis
Brought to you by: AbbVie.
Faculty:
  1. Evan Siegal, MD
CLOSE  X  
A Paradigm Shift In The Treatment of Thrombosis
Faculty:
  1. Steven Deitelzweig, MD
CLOSE  X  
Pneumococcal Pneumonia and Invasive Disease in Adults: Help Protect Your Patients Aged 50+
Faculty:
  1. Jonathan Musher, MD
CLOSE  X  
Consider the Role of the Kidney in Type 2 Diabetes Mellitus
Brought to you by: Janssen Pharmaceuticals, Inc..
Faculty:
  1. Michael Attanasio, DO

Accreditation

These educational programs are conceived and created in accordance with Accreditation Council for Continuing Medical Education (ACCME) Accreditation Criteria, the ACCME Standards for Commercial Support, and ACCME Policies. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME’s Advisory Boards and its expert review partner, Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.

Primary Care Updates
December 4, 2013
Credits Type Accreditation Statement Designation Statement
4.5 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
4.5 AAFP This live activity, Primary Care Updates, with a begin date of 12/4/2013, has been reviewed and is acceptable for up to 4.5 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Integrated Approaches to Cardiometabolic Care
December 4, 2013
Credits Type Accreditation Statement Designation Statement
4.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
4.75 AAFP This live activity, Integrated Approaches to Cardiometabolic Care, with a begin date of 12/4/2013, has been reviewed and is acceptable for up to 4.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Primary Care Updates—Track One
December 5, 2013
Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
5.25 AAFP This live activity, Primary Care Updates Track 1, with a start date of 12/05/2013, has been reviewed and is acceptable for up to 5.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education
Primary Care Updates—Track Two
December 5, 2013
Credits Type Accreditation Statement Designation Statement
7 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
7 AAFP This live activity, Primary Care Updates Track 2, with a start date of 12/05/2013, has been reviewed and is acceptable for up to 7 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
7 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 7 contact hours of continuing education
Regional Conference
December 6–7, 2013
Credits Type Accreditation Statement Designation Statement
13 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 13 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
13 AAFP This live activity, Regional Conference Baltimore, MD, with a start date of 12/06/2013, has been reviewed and is acceptable for up to 13 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
13 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 13 contact hours of continuing education (which includes 6.500 hours of pharmacology).

Faculty

Pamela Kushner, MA, MD, FAAFP (Read Bio)

Clinical Professor, Department of Family Medicine, University of California, Irvine, Irvine, CA

Presenting on:

Robert Gleeson, MD, FACP, FNLA

Presenting on:

  • Managing Hypertension and Obesity through Therapeutics and Lifestyle Modifications
    Wednesday, December 04, 2013, 9:15 AM-10:45 AM

James Underberg, MD, FASH, FNLA, MS, FACP, FACPM (Read Bio)

Presenting on:

Alan Brown, MD, FACC, FNLA, FAHA (Read Bio)

Presenting on:

  • New Advancements in Managing the Patient with Severe Dyslipidemia
    Wednesday, December 04, 2013, 11:00 AM-12:30 PM

Joseph Saseen, PharmD, FCCP, BCPS

Presenting on:

  • New Advancements in Managing the Patient with Severe Dyslipidemia
    Wednesday, December 04, 2013, 11:00 AM-12:30 PM

Yehuda Handelsman, FNLA, MD, FACP, FACE (Read Bio)

Private Practice, Endocrinologist, Tarzana, CA
Medical Director & Principal Investigator, Metabolic Institute of America, Tarzana, CA

Presenting on:

JoAnne Foody, MD, FACC, FAHA (Read Bio)

Associate Professor of Medicine, Harvard Medical School, Boston, MA
Director, Cardiovascular Wellness Program, Brigham and Women's Hospital, Boston, MA

Presenting on:

Peter Libby, FACC, MD (Read Bio)

Chief of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA
Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, MA

Presenting on:

Paul Rosenblit, MD, PhD, FACE, FNLA (Read Bio)

Clinical Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of California, Irvine, Irvine, CA
Co-Director, Diabetes Out-Patient Clinic, UC Irvine Medical Center, Orange, CA

Presenting on:

Rafael Tamargo,

Walter E. Dandy Professor of Neurosurgery, Department of Neurosurgery, Professor of Neurosurgery and Otolaryngology, Division of Cerebrovascular Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD

Presenting on:

  • Update in Diagnosis and Management of Intracranial Aneurysms for Primary Health Care Providers
    Thursday, December 05, 2013, 7:45 AM-9:00 AM

John Russell, MD (Read Bio)

Clinical Professor, Family and Community Medicine, Temple University School of Medicine, Philadelphia, PA
Director, Family Medicine Residency Program, Abington Memorial Hospital, Abington, PA

Presenting on:

  • Immunization Update 2013
    Thursday, December 05, 2013, 7:45 AM-9:00 AM

Zachary Bloomgarden, MD

Clinical Professor, Department of Medicine, Mount Sinai School of Medicine, New York, NY

Presenting on:

  • Case Work: Evaluating GLP-1 Receptor Agonists in Patient-Centered Care for Type 2 Diabetes
    Thursday, December 05, 2013, 9:15 AM-10:45 AM

James LaSalle, FAAFP, DO

Medical Director, Excelsior Springs Clinic, Excelsior Springs, MO

Presenting on:

  • Case Work: Evaluating GLP-1 Receptor Agonists in Patient-Centered Care for Type 2 Diabetes
    Thursday, December 05, 2013, 9:15 AM-10:45 AM

Scott Joy, FACP, MD (Read Bio)

Presenting on:

  • Case Work: Evaluating GLP-1 Receptor Agonists in Patient-Centered Care for Type 2 Diabetes
    Thursday, December 05, 2013, 9:15 AM-10:45 AM

Javier Morales, MD (Read Bio)

Vice President, Principal Clinical Trails Investigator, Advanced Internal Medicine Group, New Hyde Park, NY

Presenting on:

  • Incretin-Based Therapies for Type 2 Diabetes: Mechanism-Based Strategies to Achieve Patient-Centered Care
    Thursday, December 05, 2013, 9:15 AM-10:45 AM

Jeff Unger, MD, FACE, ABFM

Assistant Professor of Family Medicine, Loma Linda University School of Medicine, Riverside, CA
Director, Metabolic Studies, Catalina Research Institute, Chino, CA

Presenting on:

  • Incretin-Based Therapies for Type 2 Diabetes: Mechanism-Based Strategies to Achieve Patient-Centered Care
    Thursday, December 05, 2013, 9:15 AM-10:45 AM

Jack Leahy, MD (Read Bio)

Chief, Division of Endocrinology, Diabetes and Metabolism, University of Vermont, Burlington, VT

Presenting on:

  • Incretin-Based Therapies for Type 2 Diabetes: Mechanism-Based Strategies to Achieve Patient-Centered Care
    Thursday, December 05, 2013, 9:15 AM-10:45 AM

Jenny Lin, MD, MPH

Associate Professor, Division of General Internal Medicine, Mount Sinai School of Medicine, New York, NY

Presenting on:

  • Improving Treatment Adherence in Chronic Illness: Simple Evidence-Based Strategies for Use in Daily Practice
    Thursday, December 05, 2013, 10:45 AM-12:00 PM

Eugene Monroe, MD

Presenting on:

  • Improving Treatment Adherence in Chronic Illness: Simple Evidence-Based Strategies for Use in Daily Practice
    Thursday, December 05, 2013, 10:45 AM-12:00 PM

Deepak Bhatt, FESC, FSCAI, FACC, MD, MPH, FAHA (Read Bio)

Professor of Medicine, Harvard Medical School, Boston, MA

Presenting on:

  • Reducing Risk in the Acute Coronary Syndrome Patient: Insights for Primary Care Clinicians
    Thursday, December 05, 2013, 10:45 AM-12:15 PM

Marc Sabatine, MD, MPH

Associate Professor of Medicine, Chairman TIMI Study Group, Harvard Medical School, Boston, MA

Presenting on:

  • Reducing Risk in the Acute Coronary Syndrome Patient: Insights for Primary Care Clinicians
    Thursday, December 05, 2013, 10:45 AM-12:15 PM

Guillermo Umpierrez, MD, FACP, FACE

Professor of Medicine, Division of Endocrinology and Metabolism, Emory University School of Medicine, Atlanta, GA
Section Chief, Diabetes and Endocrinology, Director, Grady Diabetes Clinic, Grady Health System, Atlanta, GA

Presenting on:

John Anderson, MD

President, Medicine and Science, American Diabetes Association, Nashville, TN
Past President, The Frist Clinic, Nashville, TN

Presenting on:

Davida Kruger, MSN, BC-ADM, APRN

Certified Nurse Practitioner, Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, MI

Presenting on:

Paul Doghramji, FAAFP, MD (Read Bio)

Family Physician, Collegeville Family Practice, Collegeville, PA
Medical Director of Health Services, Ursinus College, Collegeville, PA

Presenting on:

  • Early Recognition and Intervention in MS: A Continuum of Care Model
    Thursday, December 05, 2013, 12:45 PM-2:00 PM

Jacqueline Nicholas, MD, MPH

Assistant Professor of Neurology, Division of Neuroimmunology, The Ohio State University, Columbus, OH

Presenting on:

  • Early Recognition and Intervention in MS: A Continuum of Care Model
    Thursday, December 05, 2013, 12:45 PM-2:00 PM

Donna Ryan, MD (Read Bio)

Professor Emeritus, Pennington Biomedical Research Center, Baton Rouge, LA

Presenting on:

  • Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
    Thursday, December 05, 2013, 1:55 PM-3:10 PM

W. Timothy Garvey, MD (Read Bio)

Butterworth Professor and Chair, Department of Nutrition Sciences, Director, UAB Diabetes Research & Training Center, University of Alabama at Birmingham, Birmingham, AL

Presenting on:

  • Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
    Thursday, December 05, 2013, 1:55 PM-3:10 PM

Vladimir Maletic, MD, MS

Clinical Professor of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC
Consulting Associate, Division of Child and Adolescent Psychiatry, Department of Psychiatry, Duke University, Durham, NC

Presenting on:

  • Five Things to Do Differently for Your Patients with Depression: Working Toward Successful Treatment
    Thursday, December 05, 2013, 2:15 PM-3:45 PM

W. Jackson, MD

Assistant Professor of Clinical Psychiatry, Department of Psychiatry, University of Tennessee, Memphis, TN
Medical Director, Methodist Alliance Hospice and Palliative Services, Memphis, TN

Presenting on:

  • Five Things to Do Differently for Your Patients with Depression: Working Toward Successful Treatment
    Thursday, December 05, 2013, 2:15 PM-3:45 PM

Adam Fleisher, MAS, MD

Director of Imaging, Banner Alzheimer's Institute, Phoenix, AZ
Medical Director, Alzheimer's Disease Cooperative Study, Phoenix, AZ
Associate Professor, Department of Neurosciences, University of California, San Diego, CA

Presenting on:

  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 6:00 AM-7:30 AM
  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 12:30 PM-2:00 PM
  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 5:45 PM-7:15 PM

Michael Rafii, MD, PhD

Director, Memory Disorders Clinic, University of California, San Diego Perlman Ambulatory Care Center, La Jolla, CA
Assistant Professor of Neurosciences, University of California, San Diego, San Diego, CA

Presenting on:

  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 6:00 AM-7:30 AM
  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 12:30 PM-2:00 PM
  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 5:45 PM-7:15 PM

Eric Tangalos, MD, FACP

Professor of Medicine, Mayo Clinic, Rochester, MN

Presenting on:

  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 6:00 AM-7:30 AM
  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 12:30 PM-2:00 PM
  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 5:45 PM-7:15 PM

Dennis Selkoe, MD

The Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical School, Boston, MA
Co-Director, Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, MA

Presenting on:

  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 6:00 AM-7:30 AM
  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 12:30 PM-2:00 PM
  • Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
    Friday, December 06, 2013, 5:45 PM-7:15 PM

Charles Argoff, MD

Assistant Professor of Neurology, New York University School of Medicine, New York, NY
Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY
Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Presenting on:

Bill McCarberg, MD (Read Bio)

Assistant Clinical Professor (voluntary), University of California, San Diego, San Diego, CA
Founder, Chronic Pain Management Program, San Diego, CA

Presenting on:

Steven Stanos, DO (Read Bio)

Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of Medicine, Chicago, IL
Chronic Pain Care Center, Chicago, IL

Presenting on:

Salvatore Mangione, MD (Read Bio)

Associate Professor of Medicine, Jefferson Medical College, Philadelphia, PA

Presenting on:

Stephen Gluckman, MD (Read Bio)

Professor of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Medical Director, Penn Global Medicine, Philadelphia, PA

Presenting on:

Danielle Duffy, FACC, MD (Read Bio)

Assistant Professor of Medicine, Division of Cardiology, Jefferson Medical College, Philadelphia, PA
Director, Cardiovascular Risk Reduction, Jefferson Heart Institute, Philadelphia, PA

Presenting on:

Gregory Piazza, MD (Read Bio)

Cardiovascular Division, Brigham and Women's Hospital, Instructor in Medicine, Harvard Medical School, Boston, MA
Education Chair, NATF, Brookline, MA

Presenting on:

Christopher Smith, MD, FACP (Read Bio)

Associate Proessor of Medicine, Harvard Medical School, Boston, MA
Associate Director, Internal Medicine Residency Program, Co-Director, Rabkin Fellowship in Medical Education, Beth Israel Deaconess Medical Center, Boston, MA

Presenting on:

Douglas Paauw, MD (Read Bio)

Professor of Medicine, Rothman Family Foundation, Endowed Chair in Patient-Centered Clinical Education, University of Washington School of Medicine, Seattle, WA

Presenting on:

Rosalind Kaplan, FACP, MD (Read Bio)

Director, Temple Health Women's Care, Temple University School of Medicine, Philadelphia, PA
Associate Professor of Clinical Medicine, Temple University School of Medicine, Philadelphia, PA

Presenting on:

Course Directors

Clyde W. Yancy, MD, MSc, FACC, FAHA, MACP

  • Magerstadt Professor of Medicine, Chief, Division of Cardiology, Northwestern University Feinberg School of Medicine
  • John J. Russell, MD

    William D. Chey, MD, AGAF, FACG, FACP

  • Professor of Medicine, Director, GI Physiology Laboratory, Co-Director, Michigan Bowel Control Program, H. Marvin Pollard Institute Scholar, Division of Gastroenterology, University of Michigan Health System
  • M. Susan Burke, MD, FACP

  • Clinical Assistant Professor, Thomas Jefferson University Medical School
  • Adjunct Clinical Associate Professor, Department of Geriatrics, Philadelphia College of Osteopathic Medicine
  • Senior Advisor, Internal Medicine Clinical Care Center, Lankenau Medical Center
  • Silvio E. Inzucchi, MD

  • Professor of Medicine, Yale University School of Medicine
  • Clinical Chief, Endocrinology, Yale-New Haven Hospital
  • Neil Skolnik, MD

  • Professor, Family and Community Medicine, Temple University School of Medicine
  • Associate Director, Family Medicine Residency Program, Abington Memorial Hospital
  • Scott C. Litin, MD, MACP

  • Professor of Medicine, Division of General Internal Medicine, Mayo Clinic College of Medicine
  • James V. Hennessey, MD, FACP

  • Associate Professor of Medicine, Harvard Medical School
  • Director, Clinical Endocrinology, Beth Isreal Deaconess Medical Center
  • Mark Zimmerman, MD

  • Professor of Psychiatry and Human Behavior, Brown Medical School
  • Director of Outpatient Psychiatry, Rhode Island Hospital, The Miriam Hospital
  • F. Wilford Germino, MD, FACP, FASH

  • Assistant Professor, Department of Internal Medicine, Rush Medical College
  • , Department of Internal Medicine, Orland Primary Care Specialists
  • Kalpana Gupta, MD, MPH

  • Associate Professor of Medicine, Boston University School of Medicine
  • Adelaide Hebert, MD

  • Professor of Dermatology and Pediatrics, University of Texas Medical School
  • John B. Bundrick, MD

  • Assistant Professor of Medicine, Mayo Clinic College of Medicine
  • Consultant in Medicine, Mayo Clinic
  • Beth L. Jonas, MD

  • Associate Professor of Medicine, Department of Medicine/Division of Rheumatology, Director, Rheumatology Fellowship Training Program, University of North Carolina School of Medicine
  • Sheila Eileen Crowe, MD, FRCPC, FACP, FACG, AGAF

    Start:  End: 
    Expand Expand Instructions Print PrintMap

    Travel Arrangements

    Meeting Location

    Baltimore Convention Center
    1 W Pratt St
    Baltimore, MD 21201-2499
    (410) 649-7000

    Hotel Accommodations